Stock listing

BAVA Stock Price, News, Filings & Events — Bavarian Nordic A/s

Selected listing: BAVA · OMXCOP · DKK · DK

This page tracks Bavarian Nordic A/s's BAVA:OMXCOP listing on OMXCOP in DKK for DK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BAVA:OMXCOP. BAVA:OMXCOP is the stock-level entry point for investors researching Bavarian Nordic A/s, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bavarian Nordic A/S is a public company listed on the Danish market under the ticker BAVA. The company has a market capitalization of approximately 2.12 billion USD. Bavarian Nordic focuses on developing and manufacturing innovative vaccines and immunotherapies.

BAVA:OMXCOPDKKDKUpdated August 22, 2026
Bavarian Nordic A/s logo
Ticker
BAVA:OMXCOP
Asset type
Stock
Market cap
$2.37B
Sector
Health Technology
Industry
Biotechnology
Exchange
OMXCOP
Currency
DKK

Bavarian Nordic A/s BAVA:OMXCOP stock context

This page tracks Bavarian Nordic A/s's BAVA:OMXCOP listing on OMXCOP in DKK for DK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BAVA:OMXCOP. BAVA:OMXCOP is the stock-level entry point for investors researching Bavarian Nordic A/s, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bavarian Nordic A/S is a public company listed on the Danish market under the ticker BAVA. The company has a market capitalization of approximately 2.12 billion USD. Bavarian Nordic focuses on developing and manufacturing innovative vaccines and immunotherapies.

Latest news from Bavarian Nordic A/s

All Bavarian Nordic A/s news →

Bavarian Nordic A/s earnings calls

Research Bavarian Nordic A/s

Alternate listings